Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01
GlobeNewswire
· Significant Phase 2 clinical trial progress obtained with first patient finalizing EVX-01 vaccine dosing
· Favorable..